-
Mashup Score: 0'Staggering' Weight Loss With Tirzepatide - 11 month(s) ago
Over 60% of participants achieved the weight-reduction target of 20% or higher and had improved body composition in a phase 3 trial of tirzepatide in overweight/obesity.
Source: MedscapeCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 1Adults with obesity lose nearly 15% of body weight with glucagon/GLP-1 receptor agonist - 12 month(s) ago
A novel glucagon/GLP-1 receptor agonist conferred nearly 15% weight loss at 46 weeks among people with overweight or obesity without type 2 diabetes, according to an industry press release. In a phase 2 clinical trial, participants with overweight or obesity and no diagnosis of type 2 diabetes were randomly assigned to subcutaneous BI 456906 (Boehringer Ingelheim and Zealand Pharma) or placebo
Source: www.healio.comCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 0Gastric inlet patch – an under-diagnosed cause of globus - 12 month(s) ago
A gastric inlet patch (GIP) is an island of heterotopic gastric mucosa found commonly in the proximal oesophagus just below the upper oesophageal sphincter. It is often underdiagnosed due to its location. Its importance and clinical relevance can be underestimated [1]. It is important to recognise as these patients can present to general practice, gastroenterology or ENT clinics with a wide…
Source: ENT & Audiology NewsCategories: Latest Headlines, OtolaryngologyTweet
-
Mashup Score: 0Eli Lilly releases more data for new obesity drug, moving toward fast-track approval - 1 year(s) ago
There’s already a huge demand for existing weight-loss drugs, so the new medication is highly anticipated. Obesity affects an estimated 650 million adults globally.
Source: NPRCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 7Microbial changes from bariatric surgery alters glucose-dependent insulinotropic polypeptide and prevents fatty liver disease - 1 year(s) ago
Bariatric surgery remains a potent therapy for nonalcoholic fatty liver disease (NAFLD), but its inherent risk and eligibility requirement limit its adoption. Therefore, understanding how bariatric…
Source: Taylor & FrancisCategories: Healthcare Professionals, Latest HeadlinesTweet-
Microbial changes from bariatric surgery alters glucose-dependent insulinotropic polypeptide and prevents fatty liver disease #microbiome #microbiota #GIP #obesity #bariatricsurgery https://t.co/GRrp4MEOoT
-
-
Mashup Score: 6Beyond the pancreas: contrasting cardiometabolic actions of GIP and GLP1 - Nature Reviews Endocrinology - 1 year(s) ago
This Review highlights the extrapancreatic actions of the incretin hormones gastric inhibitory polypeptide and glucagon-like peptide 1. These peptides are active on tissues with cardiometabolic relevance, such as liver, adipose tissue, muscle, the immune, kidney, heart, blood vessels and the central nervous system.
Source: NatureCategories: Endocrinology, Latest HeadlinesTweet
-
Mashup Score: 12
Abstract. As heart failure (HF) enters a new era with high level of evidence supporting the use of individual drug therapies, we put forth a rationale for the n
Source: OUP AcademicCategories: Cardiologists, Latest HeadlinesTweet-
The last decade established building blocks of #CaReMe. The next will drive implementation & test different drugs in combo. T2D: #SGLT2i + #GLP1RA HF & CKD: #SGLT2i + #MRA Obesity: #GLP1 + #GIP + #Glucagon Super⭐️@vbluml discusses in @escardio #EHJSuppl https://t.co/MiPfvDExIR https://t.co/hlwGQsxAuA
-
-
Mashup Score: 0Lilly Announces 2023 Financial Guidance, Plans to Launch up to Four New Medicines | Eli Lilly and Company - 1 year(s) ago
The Investor Relations website contains information about Eli Lilly and Company’s business for stockholders, potential investors, and financial analysts.
Source: Eli Lilly and CompanyCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 13
In the summer of 2018, Lisa Robillard left her doctor’s office and walked down the long corridor of a medical complex in suburban Virginia. She’d just had an appointment with yet another physician who could only recommend “diet and exercise” when she brought up her life-long struggle with her weight.
Source: Financial TimesCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 1Recurrent colonic polyps - 2 year(s) ago
A 56-year-old man presented with a change in bowel habit to seven loose non-bloody stools a day. He had previously had a sigmoid resection for an endoscopic diagnosis of colonic malignancy in 2015. Histology of the resection specimen, however, had only shown inflammatory polyps, attributed to the accompanying diverticular disease. His current colonoscopy showed two malignant looking lesions in…
Source: GutCategories: Gastroenterology, Latest HeadlinesTweet
ICYMI: 'Staggering' #WeightLoss With #Tirzepatide https://t.co/QciU3Ht5tw via @medscape #Mounjaro "Something we have sought for decades, we have finally been able to achieve" #GIP + #GLP1